KLOW

$200.00

99% Pure | USA Made | Multi Dose

The KLOW Peptide Blend is a powerful, research-backed peptide blend that synergistically combines GHK-Cu, BPC-157, TB-500, and KPV into a single, high-potency formula. Each vial provides a precise blend optimized for studies involving tissue repair, accelerated regeneration, anti-inflammatory signaling, and enhanced cellular recovery. Lab-produced, USA-made, and certified ≥99% purity, KLOW streamlines peptide research by providing consistent, reliable ratios in every dose

110 in stock

What Is KLOW Blend?

KLOW Blend is a multi-peptide research stack combining GHK-Cu, BPC-157, TB-500, and KPV in an optimized ratio to explore intersecting pathways of collagen synthesis, vascular growth, cell migration, and inflammation control—all from one 80 mg vial.

Why Choose KLOW Blend?

Choose KLOW when you need a comprehensive, time-saving solution for advanced tissue-repair and regenerative studies. Rather than managing four separate peptides, KLOW’s pre-mixed formulation ensures consistent ratios, simplifies dosing, and speeds up assay setup—so you can focus on results, not logistics.

What Sets KLOW Blend Apart?

Unlike custom mixes or sequential dosing, KLOW Blend delivers precise, pre-validated ratios of four synergistic peptides in one vial. This unified approach minimizes user error, standardizes multi-endpoint protocols, and offers unmatched convenience for multiplexed in vitro and in vivo experiments.

FAQS

To study combined effects on collagen synthesis, angiogenesis, cell migration, and inflammation in one protocol.

Add sterile water for injection at your chosen concentration (e.g., 10 mg/mL), mix gently until fully dissolved.

Yes—its 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV ratio mimics separate dosing without extra vials.

Researchers often use 1–10 µg/mL, adjusted per assay and cell type.

Common dosing: 0.1–1 mg/kg total peptide via subcutaneous injection, split into 10–100 µg/kg per component.

Store lyophilized at – 20 °C; reconstituted solution is stable for 7 days at 2–8 °C.

A blend ensures synchronized pathway activation and removes pipetting variance from separate reconstitutions.

Yes—all four peptide components are endotoxin-screened to < 0.1 EU/mg.

Can I adjust the peptide ratio?

Real Peptides offers KLOW Blend 80 mg vials, USA-made, ≥ 99% purity—strictly for research use only.

Related Products